Search filters

List of works by Roger Stupp

A novel tool to analyze MRI recurrence patterns in glioblastoma

scientific article published on 31 July 2008

Bevacizumab and recurrent malignant gliomas: a European perspective

scientific article

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

scientific article

Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro

scientific article published on December 2009

Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression

scientific article

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

scientific article published on September 2008

Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma

scientific article published on 19 January 2016

Epilepsy meets cancer: when, why, and what to do about it?

scientific article published on September 2012

Glioma.

scientific article published on 16 July 2015

Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply

scientific article published in December 2017

Individualized targeted therapy for glioblastoma: fact or fiction?

scientific article published on January 2012

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

scientific article

Lomustine and Bevacizumab in Progressive Glioblastoma

scientific article published in November 2017

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

scientific article published on 5 February 2015

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

scientific article published on 08 December 2009

Malignant astrocytoma in elderly patients: where do we stand?

scientific article published on December 2013

Molecular diagnostics of gliomas: the clinical perspective

scientific article published on 23 September 2010

Molecular neuro-oncology in clinical practice: a new horizon

scientific article published on August 2013

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas

scientific article published on 23 April 2018

Optimal management of elderly patients with glioblastoma

scientific article published on 19 June 2012

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice

scientific article

Reply to F. Felix et al and M.F. Fay et al.

scientific article published on 13 June 2016

Ribosomal protein S11 influences glioma response to TOP2 poisons

scientific article published on 11 June 2020

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

scientific article published on 22 August 2017

Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?

scientific article published on September 2010

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

scientific article published on 26 September 2016

Paulina is supported by:

About Paulina

Help